Interaction of Afobazole with σ1-Receptors

  • S. B. Seredenin
  • T. A. Antipova
  • M. V. Voronin
  • S. Yu. Kurchashova
  • A. N. Kuimov
Pharmacology and Toxicology

In vitro radioligand assay revealed interaction of afobazole with σ1-receptors (Ki=5.9 × 10—6 M). Translocation of σ1-receptors from the endoplasmic reticulum to the outer membrane was demonstrated by confocal microscopy. Experiments were performed on the model of HT-22 immortalized hippocampal cells after incubation with afobazole in a concentration of 10—8 M.

Key Words

afobazole σ1-receptor radioligand binding receptor translocation 


  1. 1.
    I. P. Galaeva, T. L. Garibova, T. A. Voronina, and S. B. Seredenin, Byull. Eksp. Biol. Med., 140, No. 11, 545-548 (2005).Google Scholar
  2. 2.
    T. A. Zenina, I. V. Gavrish, D. S. Melkumyan, et al., Ibid., 140, No. 8, 161-163 (2005).Google Scholar
  3. 3.
    S. B. Seredenin, T. A. Voronina, G. G. Neznamov, et al., Vestn. Ros. Akad. Med. Nauk, 11, 3-9 (1998).Google Scholar
  4. 4.
    S. Y. Ablordeppey and R. A. Glennon, Sigma Receptors. Chemistry, Cell Biology and Clinical Implications, Ed. R. R. Matsumoto, New York (2007), pp. 71-98.Google Scholar
  5. 5.
    E. Aydar, C. P. Palmer, V. A. Klyachko, and M. B. Jackson, Neuron, 34, No. 3, 399-410 (2002).CrossRefPubMedGoogle Scholar
  6. 6.
    Brain Damage and Repair // Molecular Research to Clinical Therapy, Eds. T. Herdegen and J. Delgado-Garcia, New York (2004).Google Scholar
  7. 7.
    M. E. Ganapathy, P. D. Prasad, W. Huang, et al., J. Pharmacol. Exp. Ther., 289, No. 1, 251-260 (1999).PubMedGoogle Scholar
  8. 8.
    T. Hayashi and T. P. Su, Ibid., 306, No. 2, 726-733 (2003).CrossRefPubMedGoogle Scholar
  9. 9.
    T. Hayashi and T. P. Su, Ibid., 306, No. 2, 718-725 (2003).CrossRefPubMedGoogle Scholar
  10. 10.
    T. Hayashi and T. P. Su, Expert Opin. Ther. Targets, 12, No. 1, 45-48 (2008).CrossRefPubMedGoogle Scholar
  11. 11.
    W. R. Martin, C. G. Eades, J. A. Thompson, et al., Pharmacol. Exp. Ther., 197, No. 3, 517-532 (1976).Google Scholar
  12. 12.
    T. A. Mavlyutov and A. E. Ruoho, J. Molec. Signal, 2, No. 3, 8 (2007).CrossRefGoogle Scholar
  13. 13.
    M. P. Morin-Surun, T. Collin, M. Denavit-Saubie, et al., Proc. Natl. Acad. Sci. USA, 96, No. 14, 8196-8199 (1999).CrossRefPubMedGoogle Scholar
  14. 14.
    A. H. Newman and A. Coop, Sigma Receptors Chemistry. Cell Biology and Clinical Implications, Ed. R. R. Matsumoto, New York (2007), pp. 25-44.Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2009

Authors and Affiliations

  • S. B. Seredenin
    • 1
  • T. A. Antipova
    • 1
  • M. V. Voronin
    • 1
  • S. Yu. Kurchashova
    • 2
  • A. N. Kuimov
    • 2
  1. 1.V. V. Zakusov Institute of PharmacologyRussian Academy of Medical SciencesMoscowRussia
  2. 2.A. N. Belozerskii Institute of Physicochemical BiologyM. V. Lomonosov Moscow State UniversityMoscowRussia

Personalised recommendations